SURVIVALAND PROGNOSTIC FACTORS FOR GLIOBLASTOMA MULTIFORME: A RETROSPECTIVE SINGLE INSTITUTIONAL STUDY-Reference-Cited by-同舟云学术

SURVIVALAND PROGNOSTIC FACTORS FOR GLIOBLASTOMA MULTIFORME: A RETROSPECTIVE SINGLE INSTITUTIONAL STUDY

Published:2020-09-01 Issue: Volume: Page:1-3
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

Gill Maneet¹,Srivastava Chinmaya¹,Agarwal Sudhanshu¹,Gautam Lokesh¹

Affiliation:

1. Department of Neurosurgery, Army Hospital (R & R) , Delhi Cantt 10

Abstract

OBJECTIVE The purpose of the present retrospective analysis was to present and discuss clinical features (Patient specific and tumour specific) and various prognostic factors that predict the survival of the patients with Glioblastoma multiforme (GBM) and to compare the results with pre-existing literature. MATERIALS &METHODS A single institutional data of 221 patients of GBM was reviewed from 2014 to 2018. Data regarding patients’ factor,tumour factor and survival analysis were collected and based on the above factor’s survival outcome was calculated. RESULTS A total of 221 patients were analysed. 197 patients underwent resection and 24 patients underwent biopsy (Open or stereotactic). Patients had a mean age of 56.5 years at the time of diagnosis. Median survival in patients < 50 years was 9.21 months and > 50 years was 4.56 months. The overall survival was 4.27% for the entire cohort at the end of two years. CONCLUSION In patients with GBM overall survival and prognosis remains dismal.Standard treatment includes resection followed bychemo-radiation which has improved the overall survivaloutcome. However, the prognosis continues to remains poor.

Publisher

World Wide Journals

Reference34 articles.

1. 1. Ries LA, Eisner MP, Kosary CL, Hankey BF, Millar BA, Clegg L, et al, editors. SEER Cancer Statistics,1973-1998. Bethesda, MD: National Cancer Institute; 2001.

2. 2. Statistical report. Primary brain tumor in US 2000-2004.Chicago. Central brain tumor registry of US,2008.

3. 3. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 2013;15 Suppl2:ii1-56

4. 4. Żukiel R, Piestrzeniewicz R, Nowak S, Jankowski R, Wieloch M. History of surgical treatment of brain tumors. Neuroskop2004;6:9-19.

5. 5. Padmalatha C, Harruff RC, GanickD,HafezGB. Glioblastoma multiforme with tuberous sclerosis. Report of a case. Arch Pathol Lab Med 1980;104:649-50.